Tobias Suske
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib.
Journal: HemaSphere
Published: October 27, 2025
Somatic STAT5BN642H mutations shape variable immune landscapes resulting in heterogenous immune diseases.
Journal: The Journal of allergy and clinical immunology
Published: September 09, 2025
Unveiling myeloid transformation: T-LGLL with eosinophilia masking myeloid-associated STAT5B mutation culminating in AML.
Journal: British journal of haematology
Published: January 21, 2024
Perinatal thymic-derived CD8αβ-expressing γδ T cells are innate IFN-γ producers that expand in IL-7R-STAT5B-driven neoplasms.
Journal: Nature immunology
Published: March 13, 2023
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Journal: The Journal of clinical investigation
Published: January 04, 2023
JAK-STAT signaling maintains homeostasis in T cells and macrophages.
Journal: Nature immunology
Published: July 22, 2022
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
Journal: Leukemia
Published: July 16, 2020
The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5.
Journal: The Journal of clinical investigation
Published: June 21, 2019
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.
Journal: Haematologica
Published: January 18, 2019
STAT5BN642H drives transformation of NKT cells: a novel mouse model for CD56+ T-LGL leukemia.
Journal: Leukemia
Published: November 14, 2018
Structural and functional consequences of the STAT5BN642H driver mutation.
Journal: Nature communications
Published: September 30, 2018
Last Updated: 09/26/2026